Details

Autor(en) / Beteiligte

• Costantini, Antonio
• Pala, Maria Immacolata
• Compagnoni, Laura
• Colangeli, Marco

Titel

High-dose thiamine as initial treatment for Parkinson's disease

Ist Teil von

• BMJ case reports, 2013-08, Vol.2013, p.bcr2013009289

Ort / Verlag

England: BMJ Publishing Group LTD

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Parkinson's disease (PD) is a systemic disease with motor and non-motor deficits. We recruited three patients with newly diagnosed PD. They were not under anti-Parkinson's therapy. Plasmatic thiamine was within healthy reference range. We performed the Unified Parkinson's Disease Rating Scale (UPDRS) and started a parenteral therapy with high doses of thiamine. The therapy led to a considerable improvement in the motor part of the UPDRS ranging from 31.3% to 77.3%. From this clinical observation, it is reasonable to infer that a focal, severe thiamine deficiency due to a dysfunction of thiamine metabolism could cause a selective neuronal damage in the centres that are typically hit in this disease. Injection of high doses of thiamine was effective in reversing the symptoms, suggesting that the abnormalities in thiamine-dependent processes could be overcome by diffusion-mediated transport at supranormal thiamine concentrations.